Drug Profile
Aciclovir monophosphate
Alternative Names: ACVMP; Acyclovir monophosphateLatest Information Update: 20 Feb 2008
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; Triangle Pharmaceuticals
- Class Antivirals
- Mechanism of Action DNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections
Most Recent Events
- 30 May 2001 Suspended-Preclinical for Herpes simplex virus infections in USA (Topical)
- 29 Jun 1998 A preclinical study has been added to the pharmacodynamics section
- 26 May 1998 Triangle Pharmaceuticals plans to suspend development after completion of preclinical and formulation studies in order to concentrate on other projects